MAPK4 and brain neoplasm: In vivo tumorigenicity monitored by In-Vivo FX Pro system every 5 days showed that downregulation of circ-MAPK4 significantly inhibited formation of xenograft brain tumors (activity of fluorescence, p < 0.05) (Fig. 7f).